AVBP — ARRIVENT BIOPHARMA INC

Ownership history in HSG Holding Ltd  ·  8 quarters on record

This page tracks every 13F SEC filing in which HSG Holding Ltd reported a position in ARRIVENT BIOPHARMA INC (AVBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.97% (2024 Q1)
Avg. % of fund
0.76%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 663,308 — 0% 0.88% $16.7M $20.12
2025 Q3 UNCHANGED 663,308 — 0% 0.68% $13.0M $18.45
2025 Q2 UNCHANGED 663,308 — 0% 0.74% $14.4M $21.77
2025 Q1 UNCHANGED 663,308 — 0% 0.82% $14.0M $18.49
2024 Q4 UNCHANGED 663,308 — 0% 0.69% $16.8M $26.64
2024 Q3 UNCHANGED 663,308 — 0% 0.74% $19.0M $23.50
2024 Q2 UNCHANGED 663,308 — 0% 0.55% $14.8M $18.55
2024 Q1 INITIATED 663,308 — — 0.97% $10.5M —
% of Fund (quarterly)    AVBP price (monthly, adj. close)

Other funds also holding AVBP

As of 2025 Q4 — sorted by position size

General Catalyst Group Management, LLC 3Y 7Y 13.56% AIHC Capital Management Ltd 12.16% Octagon Capital Advisors LP 3Y 4.81% Novo Holdings A/S 3Y 7Y 3.03% HHLR ADVISORS, LTD. 3Y 7Y 2.55% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.69% Rosalind Advisors, Inc. 1.53% Sofinnova Investments, Inc. 3Y 7Y 1.47% Fund 1 Investments, LLC 3Y 1.39% ORBIMED ADVISORS LLC 3Y 7Y 1.24%
← Back to HSG Holding Ltd Holdings